AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19748665 — intervention group
Group type: EXPERIMENTAL
Intervention: Darusentan 100 mg
Number of subjects: 379
Study 19748665 — intervention group
Group type: EXPERIMENTAL
Intervention: Darusentan 300 mg
Number of subjects: 379
Study 17680844 — intervention group
Group type: EXPERIMENTAL
Intervention: Transperineal ultrasound
Number of subjects: 46
Study 17680844 — intervention group
Group type: COMPARATOR
Intervention: Endoanal ultrasound
Number of subjects: 46
Study 15172239 — intervention group
Group type: EXPERIMENTAL
Intervention: Water seal (group 1)
Number of subjects: 145
Study 15172239 — intervention group
Group type: COMPARATOR
Intervention: Suction (group 2)
Number of subjects: 145
Study 15302013 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (1 g daily)
Number of subjects: 7000
Study 15302013 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose rosuvastatin (10 mg daily)
Number of subjects: 7000
Study 15302013 — intervention group
Group type: COMPARATOR
Intervention: Placebo for n-3 polyunsaturated fatty acids
Number of subjects: 7000
Study 15302013 — intervention group
Group type: COMPARATOR
Intervention: Placebo for rosuvastatin
Number of subjects: 7000
Study 10340154 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg methylphenidate
Number of subjects: 6
Study 10340154 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 7742677 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive health care advice through six group sessions
Number of subjects: 681
Study 7742677 — intervention group
Group type: COMPARATOR
Intervention: Usual health care advice
Number of subjects: 681
Study 7742677 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive health care advice
Number of subjects: 681
Study 2248333 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mm posterior to the corneoscleral limbus
Number of subjects: 40
Study 2248333 — intervention group
Group type: COMPARATOR
Intervention: 3.0 mm posterior to the corneoscleral limbus
Number of subjects: 40
Study 7372979 — intervention group
Group type: EXPERIMENTAL
Intervention: Bausch and Lomb Soflens contact lenses
Number of subjects: 11
Study 7372979 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocurve HCII contact lenses
Number of subjects: 11
Study 7372979 — intervention group
Group type: EXPERIMENTAL
Intervention: AOSOFT‐TM/Aquaflex hydrophilic contact lenses
Number of subjects: 11
Study 7372979 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcon Tresoft contact lenses
Number of subjects: 11
Study 31630663 — intervention group
Group type: EXPERIMENTAL
Intervention: Zumba dancing
Number of subjects: 60
Study 31630663 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 60
Study 31630663 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 31513165 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic laser radiation to the right subcostal area
Number of subjects: 50
Study 31513165 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment (oral intake of Jermuk mineral water, acupuncture, iodine‐bromine baths, massage, exercise therapy, therapeutic enemas)
Number of subjects: 50
Study 29077960 — intervention group
Group type: EXPERIMENTAL
Intervention: Locomotor training (gait training on a treadmill with body‐weight support and overground training)
Number of subjects: 347
Study 29077960 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength and balance training
Number of subjects: 347
Study 26627917 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral stimulation of HT7 with two PNS devices (1 Hz, 50 mA) during surgery
Number of subjects: 120
Study 26627917 — intervention group
Group type: COMPARATOR
Intervention: Control group (no electrical stimulation of HT7 during surgery)
Number of subjects: 120
Study 24746829 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention with increased dietary LCn-3PUFA intake
Number of subjects: 108
Study 24746829 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 108
Study 22776284 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-initiated review system (direct access group)
Number of subjects: 380
Study 22776284 — intervention group
Group type: COMPARATOR
Intervention: Regular clinician-initiated group
Number of subjects: 380
Study 19463204 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination inhaled corticosteroid and long‐acting beta(2)‐agonist (ICS/LABA) maintenance medication
Number of subjects: 509
Study 17245343 — intervention group
Group type: EXPERIMENTAL
Intervention: TEGAFIRI (UFT 250 mg m(‐2) day days 1‐14, LV 90 mg day days 1‐14, irinotecan 240 mg m(‐2) day 1; q21)
Number of subjects: 143
Study 17245343 — intervention group
Group type: EXPERIMENTAL
Intervention: TEGAFOX (UFT 250 mg m(‐2) day days 1‐14, LV 90 mg day days 1‐14, oxaliplatin 120 mg m(‐2) day 1; q21)
Number of subjects: 143
Study 17245343 — intervention group
Group type: COMPARATOR
Intervention: TEGAFIRI
Number of subjects: 143
Study 17245343 — intervention group
Group type: COMPARATOR
Intervention: TEGAFOX
Number of subjects: 143
Study 15738536 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg via 15-minute infusions every 4 weeks for 1 year)
Number of subjects: 228
Study 15738536 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 228
Study 15738536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228
Study 12118902 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited anti-IL-2R monoclonal antibody (daclizumab) 2 mg/kg intraoperatively
Number of subjects: 100
Study 12118902 — intervention group
Group type: COMPARATOR
Intervention: No induction (control)
Number of subjects: 100
Study 9613889 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory rotation
Number of subjects: 63
Study 7662626 — intervention group
Group type: EXPERIMENTAL
Intervention: Krypton laser
Number of subjects: 12
Study 7662626 — intervention group
Group type: COMPARATOR
Intervention: CW Nd:YAG laser
Number of subjects: 12
Study 31842688 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention for ICH evacuation
Number of subjects: 246
Study 31294461 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenic training (AT)
Number of subjects: 26
Study 31294461 — intervention group
Group type: COMPARATOR
Intervention: Control (closing eyes for 3 minutes)
Number of subjects: 26
Study 28391531 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone for 2 weeks
Number of subjects: 29
Study 28391531 — intervention group
Group type: COMPARATOR
Intervention: Control group (no steroid treatment)
Number of subjects: 29
Study 27296660 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation of Treatment (EOT) measure
Number of subjects: 0
Study 27296660 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment satisfaction factor
Number of subjects: 0
Study 25061426 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube (ETT)
Number of subjects: 297
Study 25061426 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 297
Study 22556050 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular warm‐up programme (15 minutes, targeting core stability, balance, and proper knee alignment, twice a week for one season)
Number of subjects: 4564
Study 22556050 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4564
Study 22556050 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular warm‐up programme
Number of subjects: 4564
Study 19837764 — intervention group
Group type: EXPERIMENTAL
Intervention: (90)Y-ibritumomab tiuxetan, 14.8 MBq/kg, as consolidation therapy after unlabeled rituximab 250 mg/m(2) on day -7
Number of subjects: 70
Study 19837764 — intervention group
Group type: EXPERIMENTAL
Intervention: (90)Y-ibritumomab tiuxetan, 14.8 MBq/kg, as consolidation therapy
Number of subjects: 70
Study 19837764 — intervention group
Group type: COMPARATOR
Intervention: Control group (no further treatment)
Number of subjects: 70
Study 16805722 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride
Number of subjects: 0
Study 14764803 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH (10 microg/kg)
Number of subjects: 14
Study 14764803 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 14
Study 14764803 — intervention group
Group type: EXPERIMENTAL
Intervention: exercise
Number of subjects: 14
Study 14764803 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH
Number of subjects: 14
Study 11733394 — intervention group
Group type: EXPERIMENTAL
Intervention: rhuMAb CD18 (0.5 or 2.0 mg/kg)
Number of subjects: 394
Study 11733394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 394
Study 9223875 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl + A
Number of subjects: 46
Study 9223875 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl + B
Number of subjects: 46
Study 9223875 — intervention group
Group type: COMPARATOR
Intervention: Epidural bupivacaine (0.25%) + A
Number of subjects: 46
Study 9223875 — intervention group
Group type: COMPARATOR
Intervention: Epidural bupivacaine + B
Number of subjects: 46
Study 7968550 — intervention group
Group type: COMPARATOR
Intervention: Control condition with no interpolated task between tests
Number of subjects: 0
Study 7968550 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal processing interpolated tasks with pictures
Number of subjects: 0
Study 7968550 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal/linguistic processing interpolated tasks with words
Number of subjects: 0
Study 2886716 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrazine sulphate (60 mg three times daily for 30 days)
Number of subjects: 12
Study 2886716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29056562 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized palliative care (SPC) at home
Number of subjects: 322
Study 29056562 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 322
Study 27758050 — intervention group
Group type: EXPERIMENTAL
Intervention: Depleting e-crossing task
Number of subjects: 156
Study 27758050 — intervention group
Group type: COMPARATOR
Intervention: Non-depleting task
Number of subjects: 156
Study 25475591 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent participation (PP) with 1 medical assistant
Number of subjects: 76
Study 25475591 — intervention group
Group type: COMPARATOR
Intervention: Medical assistant-only group (2 medical assistants)
Number of subjects: 76
Study 25475591 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent participation (PP)
Number of subjects: 76
Study 23523073 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy
Number of subjects: 38
Study 23523073 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercises
Number of subjects: 38
Study 24482856 — intervention group
Group type: EXPERIMENTAL
Intervention: Directed writing focusing on sense-making
Number of subjects: 68
Study 24482856 — intervention group
Group type: EXPERIMENTAL
Intervention: Directed writing focusing on benefit-finding
Number of subjects: 68
Study 24482856 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional, non-directed emotional disclosure
Number of subjects: 68
Study 24482856 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 68
Study 19260845 — intervention group
Group type: EXPERIMENTAL
Intervention: Maca dry extract, 2400 mg
Number of subjects: 50
Study 19260845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 15668492 — intervention group
Group type: EXPERIMENTAL
Intervention: Total alcohol intake (quartiles)
Number of subjects: 195
Study 15668492 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirit consumption (quartiles)
Number of subjects: 195
Study 15668492 — intervention group
Group type: EXPERIMENTAL
Intervention: Beer intake (quartiles)
Number of subjects: 195
Study 12893197 — intervention group
Group type: EXPERIMENTAL
Intervention: poly(L-lactide/glycolide) (PLG) suture
Number of subjects: 203
Study 12893197 — intervention group
Group type: COMPARATOR
Intervention: polypropolene (monofilament) suture
Number of subjects: 203
Study 12893197 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PLG and monofilament sutures
Number of subjects: 203
Study 10440793 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 0
Study 10440793 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 0
Study 10440793 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 0
Study 10440793 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin
Number of subjects: 0
Study 8947448 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volume of 6 ml/kg
Number of subjects: 19
Study 8947448 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volume of 8 ml/kg
Number of subjects: 19
Study 8947448 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volume of 10 ml/kg
Number of subjects: 19
Study 8947448 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volume of 14 ml/kg
Number of subjects: 19
Study 1721597 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics combined with immunomodulators
Number of subjects: 38
Study 1721597 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics
Number of subjects: 38
Study 1721597 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics with gamma-globulin
Number of subjects: 38
Study 7005778 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole combined with tobramycin
Number of subjects: 47
Study 7005778 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin combined with tobramycin
Number of subjects: 47
Study 31512717 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab 75 mg Q2W or 150 mg Q2W (depending on baseline LDL-C levels)
Number of subjects: 167
Study 31512717 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 167
Study 29952946 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous neuromuscular electrical stimulation (PNMES)
Number of subjects: 124
Study 29952946 — intervention group
Group type: COMPARATOR
Intervention: Sham PNMES
Number of subjects: 124
Study 26489744 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue coverage (group B)
Number of subjects: 600
Study 26489744 — intervention group
Group type: EXPERIMENTAL
Intervention: Oversewn SL with imbricating absorbable suture (Monocryl™; group C)
Number of subjects: 600
Study 26489744 — intervention group
Group type: EXPERIMENTAL
Intervention: Oversewn SL with barbed running suture (V lock®; group D)
Number of subjects: 600
Study 26489744 — intervention group
Group type: COMPARATOR
Intervention: No SL reinforcement (group A)
Number of subjects: 600
Study 25234040 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial infusion of 500 IU of hCG diluted in ET media
Number of subjects: 300
Study 25234040 — intervention group
Group type: COMPARATOR
Intervention: Sham infusion of ET media (Control)
Number of subjects: 300
Study 23104230 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-sunburn sunbed exposure (3 times a week)
Number of subjects: 105
Study 23104230 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily vitamin D supplementation (1000 IU)
Number of subjects: 105
Study 23104230 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 105
Study 20951986 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid (CS) injection after endoscopic balloon dilation (EBD)
Number of subjects: 29
Study 20951986 — intervention group
Group type: COMPARATOR
Intervention: Placebo after endoscopic balloon dilation (EBD)
Number of subjects: 29
Study 17659363 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal Intervention Strategy (MIS) group explored and discussed psychosocial prognostic factors.
Number of subjects: 314
Study 17659363 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 314
Study 17659363 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal Intervention Strategy (MIS)
Number of subjects: 314
Study 15573655 — intervention group
Group type: EXPERIMENTAL
Intervention: Alum in physiological saline
Number of subjects: 60
Study 15573655 — intervention group
Group type: EXPERIMENTAL
Intervention: Alum in distilled water
Number of subjects: 60
Study 15573655 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 60
Study 15573655 — intervention group
Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 60
Study 11574089 — intervention group
Group type: EXPERIMENTAL
Intervention: Artery skeletization (IMAS)
Number of subjects: 163
Study 11574089 — intervention group
Group type: COMPARATOR
Intervention: Dividing the IMA at its origin (Control)
Number of subjects: 163
Study 9608349 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone alone
Number of subjects: 11
Study 9608349 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone alone
Number of subjects: 11
Study 9608349 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone combined with naloxone
Number of subjects: 11
Study 7933469 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia plus general anesthesia before surgery (Group 3)
Number of subjects: 90
Study 7933469 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia 20 min before the end of surgery under general anesthesia (Group 2)
Number of subjects: 90
Study 7933469 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia alone (Group 1)
Number of subjects: 90
Study 2450259 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine (5 mg/h during 85 min)
Number of subjects: 24
Study 28726599 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff training on evidence-based group interventions
Number of subjects: 1108
Study 27149365 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline with hyaluronic acid (HS+HA)
Number of subjects: 0
Study 27149365 — intervention group
Group type: COMPARATOR
Intervention: Hypertonic saline (HS)
Number of subjects: 0
Study 24165436 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-aided exposure treatment (n = 34)
Number of subjects: 68
Study 24165436 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control condition (n = 34)
Number of subjects: 68
Study 24165436 — intervention group
Group type: COMPARATOR
Intervention: Women without sexual problems (N = 70)
Number of subjects: 68
Study 22554612 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-protein breakfast
Number of subjects: 136
Study 22554612 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein breakfast
Number of subjects: 136
Study 22554612 — intervention group
Group type: COMPARATOR
Intervention: Control breakfast
Number of subjects: 136
Study 20138810 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent radiotherapy and letrozole (n=75)
Number of subjects: 150
Study 20138810 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential radiotherapy and letrozole (n=75)
Number of subjects: 150
Study 18796081 — intervention group
Group type: EXPERIMENTAL
Intervention: Emails as a form of publicity
Number of subjects: 332
Study 18796081 — intervention group
Group type: EXPERIMENTAL
Intervention: Visiting GP practices as a form of publicity
Number of subjects: 332
Study 18796081 — intervention group
Group type: COMPARATOR
Intervention: Questionnaire results
Number of subjects: 332
Study 15834327 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative epidural anesthesia with morphine (Group E)
Number of subjects: 40
Study 15834327 — intervention group
Group type: COMPARATOR
Intervention: Inhalation general anesthesia with sevoflurane and intermittent intravenous administration of fentanyl (Group F)
Number of subjects: 40
Study 12022306 — intervention group
Group type: EXPERIMENTAL
Intervention: NIDCAP care
Number of subjects: 22
Study 12022306 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (Control)
Number of subjects: 22
Study 10561813 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine OROS 30 mg once daily (titrated to 60 mg if DBP > 90 mmHg)
Number of subjects: 23
Study 10561813 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine ER 5 mg once daily (titrated to 10 mg if DBP > 90 mmHg)
Number of subjects: 23
Study 10561813 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine OROS
Number of subjects: 23
Study 10561813 — intervention group
Group type: COMPARATOR
Intervention: Felodipine ER
Number of subjects: 23
Study 8722432 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril/Hydrochlorothiazide 10/12.5 mg
Number of subjects: 141
Study 8722432 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril/Hydrochlorothiazide 20/12.5 mg
Number of subjects: 141
Study 8722432 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 1916322 — intervention group
Group type: EXPERIMENTAL
Intervention: polyvinyl alcohol 1.4% + chlorobutanol 0.5%
Number of subjects: 68
Study 1916322 — intervention group
Group type: EXPERIMENTAL
Intervention: polyvinyl pyrrolidone 2% without preservative
Number of subjects: 68
Study 1916322 — intervention group
Group type: COMPARATOR
Intervention: polyvinyl pyrrolidone 2% + benzalkonium chloride 0.005%
Number of subjects: 68
Study 6891699 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol-17 beta (200 micrograms, administered every other day for 10 days)
Number of subjects: 12
Study 6891699 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (200 mg, administered every other day for 10 days)
Number of subjects: 12
Study 6891699 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydrotestosterone (200 mg, administered every other day for 10 days)
Number of subjects: 12
Study 6891699 — intervention group
Group type: COMPARATOR
Intervention: Sesame oil vehicle (Control)
Number of subjects: 12
Study 31089895 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 60
Study 31089895 — intervention group
Group type: COMPARATOR
Intervention: 2% lignocaine with 1:80,000 epinephrine
Number of subjects: 60
Study 28922507 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise before learning
Number of subjects: 88
Study 28922507 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise during learning
Number of subjects: 88
Study 28922507 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise after learning
Number of subjects: 88